BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36072971)

  • 21. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
    Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
    Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Application of Circulating Tumor Cells and Circulating Endothelial Cells in Predicting Bladder Cancer Prognosis and Neoadjuvant Chemosensitivity.
    Yang X; Lv J; Zhou Z; Feng D; Zhou R; Yuan B; Wu Q; Yu H; Han J; Cao Q; Gu M; Li P; Yang H; Lu Q
    Front Oncol; 2021; 11():802188. PubMed ID: 35186716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of aneuploid circulating tumor cells and CD31
    Zhang T; Zhang L; Gao Y; Wang Y; Liu Y; Zhang H; Wang Q; Hu F; Li J; Tan J; Wang DD; Gires O; Lin PP; Li B
    Mol Oncol; 2021 Nov; 15(11):2891-2909. PubMed ID: 34455700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization.
    Zhang Y; Li J; Wang L; Meng P; Zhao J; Han P; Xia J; Xu J; Wang L; Shen F; Zheng A; Zhou F; Fan R
    Mol Med Rep; 2019 Aug; 20(2):1551-1560. PubMed ID: 31257510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of circulating tumor cells in newly diagnosed breast cancer.
    Xu L; Jia S; Li H; Yu Y; Liu G; Wu Y; Liu X; Liu C; Zhou Y; Zhang Z; Sheng Y
    Oncol Lett; 2018 Feb; 15(2):2522-2528. PubMed ID: 29434968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the prognostic role and biological characteristics of circulating tumor cell-associated white blood cell clusters in non-small cell lung cancer.
    Li Z; Fan L; Wu Y; Niu Y; Zhang X; Wang B; Yao Y; Chen C; Qi N; Wang DD; Lin PP; Tang D; Gao W
    J Thorac Dis; 2022 May; 14(5):1544-1555. PubMed ID: 35693614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aneuploid CTC and CEC.
    Lin PP
    Diagnostics (Basel); 2018 Apr; 8(2):. PubMed ID: 29670052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
    Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
    Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
    Lin PP; Gires O; Wang DD; Li L; Wang H
    Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Atlas of Circulating Rare Cells Detected by SE-iFISH and Image Scanning Platform in Patients With Various Diseases.
    Hu B; Gong Y; Wang Y; Xie J; Cheng J; Huang Q
    Front Oncol; 2022; 12():821454. PubMed ID: 35311070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous
    Yao H; Wang Z; Yang J; Xu X; Song Y
    Ann Transl Med; 2021 Dec; 9(24):1772. PubMed ID: 35071466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of epithelial-mesenchymal transition typing of circulating tumour cells in colorectal cancer.
    Hou J; Guo C; Lyu G
    Colorectal Dis; 2020 May; 22(5):581-587. PubMed ID: 31868956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial-Mesenchymal-Transition-Like Circulating Tumor Cell-Associated White Blood Cell Clusters as a Prognostic Biomarker in HR-Positive/HER2-Negative Metastatic Breast Cancer.
    Guan X; Li C; Li Y; Wang J; Yi Z; Liu B; Chen H; Xu J; Qian H; Xu B; Ma F
    Front Oncol; 2021; 11():602222. PubMed ID: 34150608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.
    Larsson AM; Jansson S; Bendahl PO; Levin Tykjaer Jörgensen C; Loman N; Graffman C; Lundgren L; Aaltonen K; Rydén L
    Breast Cancer Res; 2018 Jun; 20(1):48. PubMed ID: 29884204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
    Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
    Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
    Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
    BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer.
    Zhou J; Wu J; Hao X; Li P; Zhang H; Wu X; Chen J; Liu J; Xiao J; Zhang S; Jiang Z; Yang Y; Hu Z; Wang T
    Front Oncol; 2022; 12():966624. PubMed ID: 35992876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.